Screener
PTC Therapeutics PTCT Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 3,049,569 | 3,104,080 |
| Stockholders’ deficit: | ||
| Common stock, $0.001 par value. Authorized 250,000,000 shares; issued and outstanding 82,882,024 shares at March 31, 2026. Authorized 250,000,000 shares; issued and outstanding 81,474,366 shares at December 31, 2025. | 81 | 80 |
| Additional paid-in capital | 2,778,026 | 2,748,335 |
| Accumulated other comprehensive income | 8,466 | 10,501 |
| Accumulated deficit | (2,967,038) | (2,964,229) |
| Total stockholders’ deficit | (180,465) | (205,313) |
| Total liabilities and stockholders’ deficit | $2,869,104 | $2,898,767 |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's total liabilities & equity?
- PTC Therapeutics (PTCT) reported total liabilities & equity of $2.87B in Q1 2026.
- How has PTC Therapeutics's total liabilities & equity changed year-over-year?
- PTC Therapeutics's total liabilities & equity increased by 8.0% year-over-year, from $2.66B to $2.87B.
- What is the long-term trend for PTC Therapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), PTC Therapeutics's total liabilities & equity has grown at a 5.6% compound annual growth rate (CAGR), from $2.21B to $2.9B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about PTC Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude